Specialization
metabolic disease, internal medicine
Focus of research
- New treatment options for patients with Fabry disease
- Overcoming the negative effect of anti αGAL antibody formation in Fabry disease
-
Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine Levels
van der Veen, S. J., Sayed, M. E., Hollak, C. E. M., Brands, M. M., Snelder, C. K. S., Boekholdt, S. M., Vogt, L., Goorden, S. M. I., van Kuilenburg, A. B. P. & Langeveld, M., 1 Oct 2023, In: Clinical Journal of the American Society of Nephrology. 18, 10, p. 1272-1282 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Fabry disease: The future is in the past
van der Veen, S. J., 2023, 240 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don't
van der Veen, S. J. & Langeveld, M., 8 Dec 2022, In: Molecular Therapy - Methods and Clinical Development. 27, p. 324-326 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications